Mannkind (MNKD) EPS (Weighted Average and Diluted) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -266.67% |
| Sep 30, 2025 | 1,302.91% |
| Jun 30, 2025 | -94.65% |
| Mar 31, 2025 | 33.33% |
| Dec 31, 2024 | -25.00% |
| Sep 30, 2024 | 500.00% |
| Jun 30, 2024 | -125.00% |
| Mar 31, 2024 | 300.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 150.00% |
| Jun 30, 2023 | 50.00% |
| Mar 31, 2023 | 42.86% |
| Dec 31, 2022 | -16.67% |
| Sep 30, 2022 | 45.45% |
| Jun 30, 2022 | -10.00% |
| Mar 31, 2022 | 9.09% |
| Dec 31, 2021 | -450.00% |
| Sep 30, 2021 | 85.71% |
| Dec 31, 2018 | 62.50% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 36.00% |
| Mar 31, 2018 | 10.71% |
| Dec 31, 2017 | 9.68% |
| Sep 30, 2017 | 11.43% |
| Jun 30, 2017 | -105.88% |
| Mar 31, 2017 | -130.36% |
| Dec 31, 2016 | -57.25% |
| Sep 30, 2016 | 496.97% |
| Jun 30, 2016 | -13.79% |
| Mar 31, 2016 | 93.27% |
| Dec 31, 2015 | -5,287.50% |